webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DBCO-PEG4-acetic-Val-Cit-PAB

  CAS No.:   Cat No.: BADC-01247   Purity: 98.0% 4.5  

DBCO-PEG4-acetic-Val-Cit-PAB is a PEGylated ADC linker with DBCO for click chemistry and valine-citrulline for enzymatic cleavage, facilitating efficient and stable antibody-drug conjugate synthesis.

DBCO-PEG4-acetic-Val-Cit-PAB

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C45H57N7O10
Molecular Weight
855.97
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

DBCO-PEG4-acetic-Val-Cit-PAB, a multifaceted bifunctional linker, is essential in the realm of antibody-drug conjugates (ADCs) and diverse bioconjugation applications. Here are four pivotal applications:

Antibody-Drug Conjugates (ADCs): Serving as a crucial linker in ADC synthesis, DBCO-PEG4-acetic-Val-Cit-PAB orchestrates the precise delivery of cytotoxic agents to cancer cells. The valine-citrulline (Val-Cit) dipeptide establishes a cleavable bond, resistant in circulation, yet cleaved by tumor enzymes, liberating the drug exclusively within the tumor microenvironment. This targeted delivery scheme minimizes harm to healthy tissues, amplifying therapeutic efficacy through intricate mechanisms.

Protein-Protein Conjugation: Transcending the ADC domain, this linker facilitates protein fusion enabling in-depth exploration of protein interactions and functional assays. The DBCO moiety engages azide groups via bioorthogonal "click" chemistry, ensuring meticulous and efficient conjugation processes. This profound application underscores its critical role in advancing novel protein therapeutics and cutting-edge biotechnological tools, contributing to the complexity of protein engineering.

Nanoparticle Functionalization: Empowering precise drug delivery through nanoparticle functionalization, DBCO-PEG4-acetic-Val-Cit-PAB allows researchers to finely tune the surface properties of nanoparticles. By attaching targeting ligands or therapeutic agents using this linker, the specificity and efficacy of drug delivery are significantly enhanced, showcasing the intricacy of drug delivery systems. This innovation excels in crafting multifunctional nanocarriers poised to revolutionize cancer therapy and imaging techniques, adding depth to nanomedicine advancements.

Cell Labeling and Tracking: In the realm of cell biology, DBCO-PEG4-acetic-Val-Cit-PAB plays a crucial role in cell labeling for nuanced tracking and imaging studies. The DBCO group enables the attachment of fluorescent dyes or imaging probes to azide-modified cells, aiding in monitoring cellular dynamics such as migration and proliferation, both in vitro and in vivo. This application shines light on the complexity of cellular behavior, providing profound insights into the intricate dynamics of cellular function and imaging technology.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methylcyclopropene-PEG4-NHS | Boc-Cystamine-Poc | Amino-PEG6-t-butyl ester | Azido-PEG1-Val-Cit-OH | Methyltetrazine-Maleimide | m-PEG4-Boc | Alkyne-PEG4-SS-PEG4-alkyne | DBCO-PEG4-acetic-Val-Cit-PAB
Send Inquiry
Verification code
Inquiry Basket